Advertisement
Document › Details
Thermo Fisher Scientific Inc.. (1/4/22). "Press Release: Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference". Waltham, MA.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 8:15 a.m. (EST). Among other topics, Mr. Casper will provide the company's current perspective on its business and expectations for future financial performance.
You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team of more than 100,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
Media Contact Information:
Ron O'Brien
Thermo Fisher Scientific
Phone: 781-622-1242
E-mail: [email protected]
Investor Contact Information:
Rafael Tejada
Thermo Fisher Scientific
Phone: 781-622-1356
E-mail: [email protected]
Record changed: 2023-06-05 |
Advertisement
More documents for Thermo Fisher (Group)
- [1] miDiagnostics N.V.. (12/4/24). "Press Release: miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific to Advance an Innovative Sterility Test and Other Quality Control Tests for use in the BioPharma Industry". Leuven....
- [2] Broken String Biosciences Ltd.. (7/24/24). "Press Release: Broken String Biosciences Appoints Steve Becker as Chief Commercial Officer". Cambridge....
- [3] Tecan Group Ltd.. (6/24/24). "Press Release: Tecan Appoints Mukta Acharya Head of the Life Sciences Business Division". Männedorf....
- [4] Thermo Fisher Scientific Inc.. (10/17/23). "Press Release: Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics". Waltham, MA & Uppsala....
- [5] Exothera S.A.. (2/1/23). "Press Release: Exothera Announces the Appointment of Darren Leva as Chief Business Officer". Jumet....
- [6] Thermo Fisher Scientific Inc.. (10/31/22). "Press Release: Thermo Fisher Scientific to Acquire The Binding Site Group". Waltham, MA....
- [7] Element Biosciences, Inc.. (5/23/22). "Press Release: Element Appoints Mark Aitkenhead, PhD, as Chief Commercial Officer"....
- [8] Yposkesi. (2/28/22). "Press Release: Yposkesi, an SK pharmteco Company, Appoints US-based Executive Director for Business Development". Corbeil-Essonnes....
- [9] Bico Group AB. (11/15/21). "Press Release: Cellenion Announces Co-marketing Agreement for Single Cell Mass Spectrometry-based Proteomics Analysis"....
- [10] Thermo Fisher Scientific Inc.. (9/23/21). "Press Release: Thermo Fisher Scientific Opens Biologics Manufacturing Site in Lengnau, Switzerland". Bremen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top